Intelligence · Clinical Development
Pipeline search results
Programs matching “ischemic stroke” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 60 pipeline programs matching "ischemic stroke" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
0.9% Sodium Chloride Solution, Glenzocimab
Pari Pharma GmbH
Acute ischemic stroke
1 trial -
Asundexian (BAY2433334)
Bayer HealthCare AG
Prevention of Ischemic Stroke
1 trial -
DM199-2021-001
DiaMedica Therapeutics
Acute Ischemic Stroke
1 trial -
Direct endovascular clot retrieval
Neuroscience Trials Australia
Ischemic Stroke
1 trial -
Galantamine
Universal Integrated
Acute Ischemic Stroke AIS
1 trial -
Ginkgo Diterpene Lactone Meglumine Injection
Universal Integrated
Ischemic Stroke
1 trial -
Ginkgo diterpene lactone meglumine injection
Universal Integrated
Ischemic Stroke, Acute
1 trial -
IIBSP-SAV-2025-178
The George Institute
Acute ischemic stroke
1 trial -
Intra-arterial thrombolysis
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Ischemic Stroke
1 trial -
Intravenous thrombolysis plus tirofiban
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Ischemic Stroke
1 trial -
Intravenous thrombolysis plus tirofiban
Hospital Authority, Hong Kong
Acute Ischemic Stroke
1 trial -
JX10002
Lacuna Pharma Pty Ltd
Acute ischemic stroke
1 trial -
Low-dose rtPA
Takeda
Ischemic Stroke
1 trial -
Metalyse 5 000 units (25 mg) powder for solution for injection
Boehringer Ingelheim
Acute Ischemic Stroke
1 trial -
Methylprednisolone sodium succinate
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
PCSK9 inhibitors combined with atorvastatin/rosuvastatin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Ischemic Stroke
1 trial -
Sovateltide, Sovateltide matching placebo
Lacuna Pharma Pty Ltd
Acute cerebral ischemic stroke
1 trial -
TNK-tPA
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
Tenecteplase
Hospital Authority, Hong Kong
Ischemic Stroke
1 trial -
The methylprednisolone sodium succinate
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
Tirofiban
Universal Integrated
Acute Ischemic Stroke
1 trial -
Vanish Trial
The George Institute
People with acute ischemic stroke (AIS) due to large vessel occlusion of the anterior circulation.
1 trial -
[2025]372-001
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Ischemic Stroke
1 trial -
rt-PA
Beijing Tiantan Hospital
Acute Ischemic Stroke
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.